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Case presentation 
A 34-year-old male presented to the Otorhinolaryngology Outpatient Clinic with primary 
complaint of non-specific neck pain and was found to have left-sided submandibular 
lymphadenopathy on physical examination. A fine needle aspiration biopsy (FNAB) of the 
lymph nodes (LN) was performed. An initial diagnosis of malignant salivary gland neoplasm 
was made. To further delineate the tumour location, magnetic resonance imaging (MRI) of the 
neck was done. It revealed pathologically enlarged LN; however, no abnormalities in the 
salivary glands were noticed (Fig. 1). Therefore, PET scan with 18F-FDG was carried out to 
locate the primary tumour site. It revealed an active metabolic process in several LNs of the 
upper and middle neck regions (Fig. 2). In light of these imaging studies, the patient was 
taken for bilateral tonsillectomy, adenoidectomy, and selective neck dissection of level II 
LNs. Histopathological examination revealed macro-metastasis of medullary thyroid 
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carcinoma (MTC) in these lymphoid tissues. On immunohistochemistry, the specimens 
stained positively for synaptophysin, chromogranin A, and calcitonin. Meanwhile, the serum 
calcitonin level was 300 ng/mL. 
With the suspicion of thyroid cancer, a multidisciplinary discussion was held, which 
qualified the patients for a radical thyroidectomy with radical neck dissection. The resected 
specimens were evaluated by two experienced histopathologists, which resulted in 
identification of multifocal papillary thyroid carcinoma (PTC) in the thyroid gland 
(pT1a[m]N0) and positive MTC metastases in central and left-sided LNs (levels II–IV). 
Congruent to MRI and PET scan, histopathological examination also failed to determine the 
site of primary MTC tumour (pTxN1b) (Fig. 3, 4).  
The postoperative period was uneventful. MEN2 syndrome was excluded on the basis 
of negative MRI for pheochromocytoma and negative genetic tests for RET and BRAF 
mutations. On one-year follow-up, the patient was doing well with serum calcitonin level 
below 2 pg/mL.  
 Simultaneous medullary (MTC) and papillary thyroid carcinoma is extremely rare [1]. 
To our knowledge, such coexistence without the identification of a primary tumour site for 
either carcinoma has never been reported. In our case, the primary origin of MTC was not 
identified even after extensive imaging tests and histopathological examination of 
thyroidectomy specimen (by two experienced pathologists). When a diligent search fails to 
disclose the primary lesion, then the metastatic disease is classified as “carcinoma of 
unknown primary” syndrome [2]. This may have occurred in our case, because the primary 
MTC was small in size, induced metastasis, and then regressed completely while metastatic 
lesion proliferated in the LNs [3].  
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Figure 1. MRI with pathological lymph nodes with no abnormalities in salivary glands (green 
arrows) 
 
Figure 2. PET with 18F-FDG showed active metabolic process in several lymph nodes of the 
upper and middle part of the neck (green arrows) 
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Figure 3. Histological images of both neoplasms. Nodal metastasis of the medullary 
carcinoma composed of cells with grainy (salt and pepper) chromatin showing TTF-1 and 
calcitonin expression (upper and lower inlet, respectively) 
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Figure 4. A small focus of papillary carcinoma in the thyroid gland (green arrow) 
 
